📊 PSNL Key Takeaways
Is Personalis, Inc. (PSNL) a Good Investment?
Personalis exhibits deteriorating fundamentals with declining revenue (-17.7% YoY), massive operating losses (-126.4% margin), and negative free cash flow (-$79.5M), indicating an unsustainable business model. While the company maintains a strong cash position ($124.2M) and low leverage, the burn rate and lack of profitability suggest significant distress absent a major operational turnaround.
Why Buy Personalis, Inc. Stock? PSNL Key Strengths
- Strong liquidity with $124.2M cash and 6.76x current ratio enabling near-term operational continuity
- Low leverage with 0.08x debt-to-equity ratio minimizing bankruptcy risk
- Solid stockholders' equity base of $261.2M providing financial cushion
PSNL Stock Risks: Personalis, Inc. Investment Risks
- Revenue declining 17.7% YoY with negative free cash flow of $79.5M indicating unsustainable burn rate despite liquid reserves
- Operating margin of -126.4% and net margin of -116.7% reflect fundamental business model failure with no visible path to profitability
- Gross margin of only 9.4% suggests severe cost structure challenges and inability to achieve economies of scale in laboratory services
Key Metrics to Watch
- Revenue stabilization and return to growth or exit from decline
- Gross margin expansion and progress toward operating profitability
- Operating and free cash flow improvement to assess business sustainability
Personalis, Inc. (PSNL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 6.76x current ratio provides a solid financial cushion.
PSNL Profit Margin, ROE & Profitability Analysis
PSNL vs Healthcare Sector: How Personalis, Inc. Compares
How Personalis, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Personalis, Inc. Stock Overvalued? PSNL Valuation Analysis 2026
Based on fundamental analysis, Personalis, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Personalis, Inc. Balance Sheet: PSNL Debt, Cash & Liquidity
PSNL Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Personalis, Inc.'s revenue has remained relatively flat over the 5-year period, with a 1% decline. The most recent EPS of $-1.37 indicates the company is currently unprofitable.
PSNL Revenue Growth, EPS Growth & YoY Performance
PSNL Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $14.5M | -$21.7M | $-0.24 |
| Q2 2025 | $17.2M | -$12.8M | $-0.23 |
| Q1 2025 | $19.5M | -$13.0M | $-0.18 |
| Q3 2024 | $18.2M | -$29.1M | $-0.60 |
| Q2 2024 | $16.7M | -$12.8M | $-0.24 |
| Q1 2024 | $18.9M | -$13.0M | $-0.26 |
| Q3 2023 | $14.9M | -$26.5M | $-0.58 |
| Q2 2023 | $16.7M | -$24.0M | $-0.50 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Personalis, Inc. Dividends, Buybacks & Capital Allocation
PSNL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Personalis, Inc. (CIK: 0001527753)
📋 Recent SEC Filings
| Date | Form | Document | Action |
|---|---|---|---|
| Apr 2, 2026 | DEF 14A | psnl-20260401.htm | View → |
| Mar 17, 2026 | 4 | xslF345X05/form4-03172026_080312.xml | View → |
| Mar 17, 2026 | 4 | xslF345X05/form4-03172026_080346.xml | View → |
| Mar 17, 2026 | 4 | xslF345X05/form4-03172026_080326.xml | View → |
| Mar 17, 2026 | 4 | xslF345X05/form4-03172026_080357.xml | View → |
❓ Frequently Asked Questions about PSNL
What is the AI rating for PSNL?
Personalis, Inc. (PSNL) has an AI rating of SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PSNL's key strengths?
Claude: Strong liquidity with $124.2M cash and 6.76x current ratio enabling near-term operational continuity. Low leverage with 0.08x debt-to-equity ratio minimizing bankruptcy risk.
What are the risks of investing in PSNL?
Claude: Revenue declining 17.7% YoY with negative free cash flow of $79.5M indicating unsustainable burn rate despite liquid reserves. Operating margin of -126.4% and net margin of -116.7% reflect fundamental business model failure with no visible path to profitability.
What is PSNL's revenue and growth?
Personalis, Inc. reported revenue of $69.6M.
Does PSNL pay dividends?
Personalis, Inc. does not currently pay dividends.
Where can I find PSNL SEC filings?
Official SEC filings for Personalis, Inc. (CIK: 0001527753) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PSNL's EPS?
Personalis, Inc. has a diluted EPS of $-0.91.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PSNL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Personalis, Inc. has a SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PSNL stock overvalued or undervalued?
Valuation metrics for PSNL: ROE of -31.1% (sector avg: 15%), net margin of -116.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy PSNL stock in 2026?
Our dual AI analysis gives Personalis, Inc. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PSNL's free cash flow?
Personalis, Inc.'s operating cash flow is $-74.9M, with capital expenditures of $4.5M. FCF margin is -114.1%.
How does PSNL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -116.7% (avg: 12%), ROE -31.1% (avg: 15%), current ratio 6.76 (avg: 2).